(Q49217905)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Does olanzapine inhibit the psychomimetic effects of Δ⁹-tetrahydrocannabinol? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

0 references

Hendrik Daniël Kleinloog

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Marieke Liem-Moolenaar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Gabriël Jacobs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Erica Klaassen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Marieke de Kam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ron Hijman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Joop van Gerven

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

16 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

1307-1316

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Cannabis and anxiety: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Cannabis and psychosis/schizophrenia: human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Biomarkers for the effects of antipsychotic drugs in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Animal models of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Reduced Stroop interference for opponent colors may be due to input factors: evidence from individual differences and a neural network simulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Central nervous system effects of haloperidol on THC in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Assessing evidence for a causal link between cannabis and psychosis: A review of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Psychomotor and memory effects of haloperidol, olanzapine, and paroxetine in healthy subjects after short-term administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Animal models of neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Can recreational doses of THC produce significant dopamine release in the human striatum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Estimation of pupil size by digital photography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

Effect of intrapulmonary tetrahydrocannabinol administration in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112446534

21 January 2018

Identifiers

DOI

10.1177/0269881112446534

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22596206%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference